Residue Concentrations of Cloxacillin in Milk after Intramammary Dry Cow Treatment Considering Dry Period Length
Animals · 08.08.2023 · 13 (16) · 2558
DOI: 10.3390/ani13162558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animals, online erschienen am 08.08.2023. Verfasst von Carola Fischer-Tenhagen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Animal Reproduction, Faculty of Veterinary Medicine, Freie Universität Berlin, Königsweg 65, 14163 Berlin, Germany. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Office of Consumer Protection and Food Safety, Freie Universität Berlin.
Abstract (Originalsprache)
Dry cow treatment with an intramammary antibiotic is recommended to reduce the risk of mastitis at the beginning of the next lactation. The dry period may be shortened unintentionally, affecting antibiotic residue depletion and the time when residues reach concentrations below the maximum residue limit (MRL). The objective of this study was to evaluate residue depletion in milk after dry cow treatment with cloxacillin, considering dry periods of 14 (G14d), 21 (G21d), and 28 d (G28d). Overall, fifteen cows with 60 udder quarters were included in the study. For each cow, three of the udder quarters were treated with 1000 mg cloxacillin benzathine (2:1) on d 252, d 259, and d 266 of gestation; one quarter was left untreated. Milk samples were drawn until 20 DIM and milk composition, somatic cell count and cloxacillin residues were analyzed. The HPLC-MS/MS revealed different excretion kinetics for the compounds cloxacillin and cloxacillin benzathine (1:1). All cows showed a cloxacillin and cloxacillin benzathine (1:1) concentration below the MRL of 30 µg/kg after 5 d. In the udder quarters of G21d and G28d, the cloxacillin concentration was already below the MRL at first milking after calving. The cloxacillin benzathine (1:1) concentration in the milk of G28d, G21d, and G14d fell below 30 µg/kg on the 5th, 3rd, and 5th DIM, respectively. Shortening the dry period affects residue depletion after dry cow treatment with cloxacillin. The risk of exceeding the MRL, however, seems low, even with dry periods shorter than 14 d.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic for Animal Reproduction, Faculty of Veterinary Medicine, Freie Universität Berlin, Königsweg 65, 14163 Berlin, Germany.
- Center for Protection of Experimental Animals, German Federal Institute for Risk Assessment (BfR), Alt Marienfelde 17-21, 12277 Berlin, Germany.
- Federal Office of Consumer Protection and Food Safety (BVL), Gerichtstraße 49, 13347 Berlin, Germany.
- Clinic for Ruminants, Faculty of Veterinary Medicine, Justus-Liebig-Universität Giessen, Frankfurter Str. 104, 35392 Giessen, Germany.
ORCID-Profile: Carola Fischer-Tenhagen, Sebastian Arlt, Peter L Venjakob
Förderung
- Federal Office of Consumer Protection and Food Safety
- Freie Universität Berlin
Zitieren
APA
Fischer-Tenhagen, C., Bohm, D., Finnah, A., Arlt, S., Schlesinger, S., Borchardt, S., Sutter, F., Tippenhauer, C. M., Heuwieser, W., & Venjakob, P. L. (2023). Residue Concentrations of Cloxacillin in Milk after Intramammary Dry Cow Treatment Considering Dry Period Length. Animals, 13(16), 2558. https://doi.org/10.3390/ani13162558
Vancouver
Fischer-Tenhagen C, Bohm D, Finnah A, Arlt S, Schlesinger S, Borchardt S, et al. Residue Concentrations of Cloxacillin in Milk after Intramammary Dry Cow Treatment Considering Dry Period Length. Animals. 2023;13(16):2558. doi:10.3390/ani13162558
BibTeX
@article{FischerTenhagen2023,
author = {Fischer-Tenhagen, Carola and Bohm, Detlev and Finnah, Anke and Arlt, Sebastian and Schlesinger, Samira and Borchardt, Stefan and Sutter, Franziska and Tippenhauer, Christie M and Heuwieser, Wolfgang and Venjakob, Peter L},
title = {Residue Concentrations of Cloxacillin in Milk after Intramammary Dry Cow Treatment Considering Dry Period Length},
journal = {Animals},
year = {2023},
volume = {13},
number = {16},
pages = {2558},
doi = {10.3390/ani13162558}
}
EUVIMED